Category: Wall Street BeatSyndicate content

EQT frontrunner for Siemens hearing-aids business: sources

October 22, 2014 by MassDevice

Siemens is in advanced talks to sell its hearing-aids business to private equity shop EQT, unnamed sources tell Reuters.

EQT frontrunner for Siemens hearing-aids business: sources

Abbott to go ahead with $5.3B Mylan deal, says 3rd-quarter sales match forecasts

October 22, 2014 by MassDevice

Abbott says it will go ahead with its plan to deal its generic pharmaceuticals line to Mylan for $5.3 billion and reports 3rd-quarter sales in line with expectations.

Abbott to go ahead with $5.3B Mylan deal, says 3rd-quarter sales match forecasts

Covidien, Medtronic shares jump on affirmation of $43B merger

October 22, 2014 by Brad Perriello

Shares of Medtronic and Covidien gain after Medtronic affirms its $43 billion acquisition plans, saying it now expects to close the deal for Covidien late this year or early in 2015.

Covidien, Medtronic shares jump on affirmation of $43B merger

GI Dynamics proposes 1-for-10 reverse stock split

October 21, 2014 by Val Kennedy

GI Dynamics shareholders are slated to vote on whether to approve a 1-for-10 reverse stock split in an effort to raise the company's lagging share price.

GI Dynamics proposes 1-for-10 reverse stock split

Allergan says it stands by statements on Valeant

October 21, 2014 by MassDevice

Allergan says there's no evidence to back claims by hostile suitors Valeant Pharmaceuticals and hedge mogul William Ackman's Pershing Square Capital Management that Allergan CEO David Pyott led a smear campaign against them.

Allergan says it stands by statements on Valeant

Breast implant maker Sientra sets IPO range

October 20, 2014 by Alexander Soule

Breast implant maker Sientra raised the upper limit on its planned initial public offering of stock to $92 million, after filing in mid-September for an $86 million IPO.

Breast implant maker Sientra sets IPO range

Breast implant maker Sientra set a price range for its planned initial public offering and raised the upper limit to $92 million, after filing in mid-September for an $86 million IPO. 

GE CEO Immelt: Global experience got Flannery the top spot at GE Healthcare

October 20, 2014 by Brad Perriello

John Flannery's experience in global markets landed him the top spot at GE Healthcare, where he replaced John Dineen, GE CEO Jeffrey Immelt told analysts last week.

GE CEO Immelt: Global experience got Flannery the top spot at GE Healthcare
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp